CCXI
BLANK CHECKSChemoCentryx, Inc. (CCXI) [ST]
▼ 2.29%
prev close
Churchill Capital Corp XI is a blank check company.
Congressional Trades
5
All tracked trades
Members Trading
1
Unique members
Net Activity
-1
2 buys · 3 sells
Members Who Traded This Stock
5 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2022-10-20 | CCXIChemoCentryx, Inc. | Sell | $1,001 - $15,000 | 1350d ago | — | |
| 2022-08-11 | CCXIChemoCentryx, Inc. | Sell | $1,001 - $15,000 | 1405d ago | — | |
| 2022-04-19 | CCXIChemoCentryx, Inc. | Buy | $1,001 - $15,000 | 1528d ago | — | |
| 2022-03-15 | CCXIChemoCentryx, Inc. | Sell | $1,001 - $15,000 | 1557d ago | — | |
| 2021-12-02 | CCXIChemoCentryx, Inc. | Buy | $1,001 - $15,000 | 1654d ago | — |
2022-10-20
Josh Gottheimer
CCXI
Amount
$1,001 - $15,000
Filed
1350d ago
2022-08-11
Josh Gottheimer
CCXI
Amount
$1,001 - $15,000
Filed
1405d ago
2022-04-19
Josh Gottheimer
CCXI
Amount
$1,001 - $15,000
Filed
1528d ago
2022-03-15
Josh Gottheimer
CCXI
Amount
$1,001 - $15,000
Filed
1557d ago
2021-12-02
Josh Gottheimer
CCXI
Amount
$1,001 - $15,000
Filed
1654d ago
Recent News
Powered by Polygon.io
ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings
Is ChemoCentryx (CCXI) Stock Outpacing Its Medical Peers This Year?
ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
Trade Timeline
Congressional activity, newest first
Josh Gottheimer
2022-10-20 · Sale
$1,001 - $15,000
Josh Gottheimer
2022-08-11 · Sale
$1,001 - $15,000
Josh Gottheimer
2022-04-19 · Purchase
$1,001 - $15,000
Josh Gottheimer
2022-03-15 · Sale
$1,001 - $15,000
Josh Gottheimer
2021-12-02 · Purchase
$1,001 - $15,000